The University of Chicago Header Logo

Connection

Veeral Sheth to Receptors, Vascular Endothelial Growth Factor

Back to Details
This is a "connection" page, showing publications Veeral Sheth has written about Receptors, Vascular Endothelial Growth Factor.
Veeral Sheth
Connection Strength
0.261
Receptors, Vascular Endothelial Growth Factor
  1. ACTINOMYCES NEUII ENDOPHTHALMITIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION. Retin Cases Brief Rep. 2017 Summer; 11(3):281-282.
    View in: PubMed
    Score: 0.150
  2. Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial. JAMA Ophthalmol. 2023 Dec 01; 141(12):1152-1160.
    View in: PubMed
    Score: 0.059
  3. A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2022 07; 239:180-189.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.